tirzepatide heart disease Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Failure: SUMMIT CMR Substudy Tirzepatide and Cardiovascular Outcomes: A
Description
In the trial, 201 adolescents with obesity were randomly assigned to once-weekly semaglutide 2.4 mg plus lifestyle intervention (n = 134) or placebo (n = 67) for 68 weeks
in the second half of 2024
Yeah, because I've already seen it
For detailed guidance, see our foods to avoid on tirzepatide guide, which also covers foods to emphasize
Timing: Sip slowly
Starting at a low dose and increasing gradually over weeks or months means that the full therapeutic dose is reached after the gastrointestinal system has had time to adjust to lower amounts of the medication
